Prospective observational study to assess the long term safety profile of venetoclax in a Swedish cohort of Chronic Lymphocytic Leukaemia (CLL) patients First published 12/06/2017 Last updated 06/05/2024 EU PAS number:EUPAS19010 Study Ongoing